July 14,2006
Chairman Grassley Questions CMS, FDA About Substituted Inhalation Drugs
Please see the printer-friendly version of Chairman Grassley's letter CMS and FDA regarding substituted inhalation drugs.
Next Article Previous Article
Recent News
- Crapo Statement on Meeting With CMS Administrator Nominee
- Finance Committee Advances HHS Secretary Nominee
- Crapo Statement at Executive Session to Vote on HHS Nominee
- Crapo, Wyden Announce Senate Finance Subcommittee Assignments
- Finance Committee Members Introduce Bipartisan Legislation to Ensure Medicare Patients’ Access to Cancer Detection Technologies